T

Thorne Healthtech Inc
F:F7G

Watchlist Manager
Thorne Healthtech Inc
F:F7G
Watchlist
Price: 11.8 EUR 3.51%
Market Cap: €637.6m

Thorne Healthtech Inc
Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Thorne Healthtech Inc
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
T
Thorne Healthtech Inc
F:F7G
Cash Equivalents
$74.9m
CAGR 3-Years
-2%
CAGR 5-Years
21%
CAGR 10-Years
4%
Estee Lauder Companies Inc
NYSE:EL
Cash Equivalents
$3.1B
CAGR 3-Years
-6%
CAGR 5-Years
-11%
CAGR 10-Years
14%
Bellring Brands Inc
NYSE:BRBR
Cash Equivalents
$64.1m
CAGR 3-Years
13%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Coty Inc
NYSE:COTY
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inter Parfums Inc
NASDAQ:IPAR
Cash Equivalents
$158.1m
CAGR 3-Years
15%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
elf Beauty Inc
NYSE:ELF
Cash Equivalents
$196.8m
CAGR 3-Years
31%
CAGR 5-Years
41%
CAGR 10-Years
30%
No Stocks Found

Thorne Healthtech Inc
Glance View

Market Cap
637.6m EUR
Industry
Consumer products

Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. The company is headquartered in Summerville, South Carolina and currently employs 496 full-time employees. The company went IPO on 2021-09-23. The firm is developing solutions and personalized approaches to health and well-being. The firm's brands, Thorne and Onegevity, provides insights and personalized data, products and services that help individuals take a proactive approach to maintain their health over their lifetime. The firm's Onegevity, is a multi-omics database that uses artificial intelligence (AI) and machine learning to provide insights, with its nutritional supplements. Its Thorne products support the optimization of health and include health tests, education and nutritional supplement products. The firm offers health tests to generate comprehensive, personalized, molecular portraits for its customers. Its portfolio of health tests includes tests focused on sleep, stress, weight management, gut health, heavy metals, and biological age.

F7G Intrinsic Value
37.81 EUR
Undervaluation 69%
Intrinsic Value
Price €11.8
T

See Also

What is Thorne Healthtech Inc's Cash Equivalents?
Cash Equivalents
74.9m USD

Based on the financial report for Dec 31, 2025, Thorne Healthtech Inc's Cash Equivalents amounts to 74.9m USD.

What is Thorne Healthtech Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
4%

Over the last year, the Cash Equivalents growth was 38%. The average annual Cash Equivalents growth rates for Thorne Healthtech Inc have been -2% over the past three years , 21% over the past five years , and 4% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett